Medium impact
Femoroacetabular Impingement Surgery
Regence BlueShield·Effective Oct 1, 2026
This is a new medical policy (effective October 1, 2026) establishing coverage criteria for femoroacetabular impingement (FAI) surgery. The policy requires patients to meet strict criteria including skeletally mature status, moderate-to-severe hip pain unresponsive to 3+ months of conservative therapy, positive clinical impingement signs, imaging confirmation of FAI morphology, and absence of contraindications (advanced osteoarthritis, joint space <2mm, severe femoral retroversion/anteversion, broken Shenton line, or Tonnis angle >13-15 degrees). Billing teams must prepare authorization workflows and documentation requirements before October 1, 2026.